9,979.10152.95
Stock Analysis, IPO, Mutual Funds, Bonds & More

Trending stocks: Sun Pharma shares slip 4%

Shares of Sun Pharmaceutical Industries Ltd. traded 4.09 per cent down in trade at 09:29AM on Monday .

ETMarkets.com|
Last Updated: Mar 30, 2020, 09.31 AM IST
0Comments
Agencies
Sun-Pharma-others
The stock quoted a 52-week high of Rs 640.75 and a 52-week low of Rs 317.85 .
NEW DELHI: Shares of Sun Pharmaceutical Industries traded 4.09 per cent down in Monday 's trade at 09:29 am.
Around 1309291 shares changed hands on the counter. The stock opened at Rs 321.65 and touched an intraday high and low of Rs 329.5 and Rs 312.0 , respectively, in the session so far.

The stock quoted a 52-week high of Rs 640.75 and a 52-week low of Rs 317.85 .

USFDA has classified Halol facility in Gujarat as Official Action Indicated (OAI). The US health regulator had inspected the facility from December 3 to December 13, and had issued eight observations, the company had earlier said in a regulatory filing in December.

Financials
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 81133.51 Crore) operating in Pharmaceuticals sector.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 8038.65 Crore, up 1.13 % from last quarter Sales of Rs 7949.19 Crore and up 4.99 % from last year same quarter Sales of Rs 7656.71 Crore Company has reported net profit after tax of Rs 1023.71 Crore in latest quarter.

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9783.29 Crore to Sales Value (94.95 % of Total Sales) and Other Operating Revenue which contributed Rs 519.92 Crore to Sales Value (5.04 % of Total Sales)for the year ending 31-Mar-2019.

Promoters holding
Promoters held 54.559093 per cent stake in the company as of Dec 2019 . For the quarter ended Dec 2019 , the company reported a net sales of Rs 8038.65 crore and net profit of Rs 1023.71 crore.

Valuation ratio
It quoted a price-to-earnings ratio of 19.76 and price to book value of 1.81 .

Also Read

Trending stocks: Sun Pharma shares up nearly 1%

Sun Pharma shares dip 2% on forensic audit of books

Sun Pharma shares lacklustre ahead of Q3 numbers

Know 5 things before buying Sun Pharma shares

Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service